[
  {
    "ts": null,
    "headline": "1 Analyst Thinks This Former Pandemic Winner Could Surge 500% This Year",
    "summary": "This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so again.",
    "url": "https://finnhub.io/api/news?id=5d21834ef105236d17ec2d88dd30b79123f2f45f927f7800826da97f3ebd928f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753813674,
      "headline": "1 Analyst Thinks This Former Pandemic Winner Could Surge 500% This Year",
      "id": 136129862,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so again.",
      "url": "https://finnhub.io/api/news?id=5d21834ef105236d17ec2d88dd30b79123f2f45f927f7800826da97f3ebd928f"
    }
  },
  {
    "ts": null,
    "headline": "Curious about Moderna (MRNA) Q2 Performance? Explore Wall Street Estimates for Key Metrics",
    "summary": "Evaluate the expected performance of Moderna (MRNA) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
    "url": "https://finnhub.io/api/news?id=fc9774dfa1c4ca79324ddaf78878034fb8b7fac53ef2da355b5b214bebeb477c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753794903,
      "headline": "Curious about Moderna (MRNA) Q2 Performance? Explore Wall Street Estimates for Key Metrics",
      "id": 136119863,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Evaluate the expected performance of Moderna (MRNA) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
      "url": "https://finnhub.io/api/news?id=fc9774dfa1c4ca79324ddaf78878034fb8b7fac53ef2da355b5b214bebeb477c"
    }
  },
  {
    "ts": null,
    "headline": "dbt Labs Signs Strategic Collaboration Agreement with AWS",
    "summary": "dbt Labs, the leader in standards for AI-ready structured data, today announced it has signed a strategic collaboration agreement (SCA) with Amazon Web Services (AWS). The agreement will expand technical integrations across services including Amazon Redshift, Amazon Athena, and Amazon SageMaker Lakehouse, while also expanding AWS Marketplace availability to simplify access and procurement for enterprise customers.",
    "url": "https://finnhub.io/api/news?id=60627de917ec9d6a26916a3bffd4d62094700a65c094a9e262a4238a973a3a68",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753794000,
      "headline": "dbt Labs Signs Strategic Collaboration Agreement with AWS",
      "id": 136119034,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "dbt Labs, the leader in standards for AI-ready structured data, today announced it has signed a strategic collaboration agreement (SCA) with Amazon Web Services (AWS). The agreement will expand technical integrations across services including Amazon Redshift, Amazon Athena, and Amazon SageMaker Lakehouse, while also expanding AWS Marketplace availability to simplify access and procurement for enterprise customers.",
      "url": "https://finnhub.io/api/news?id=60627de917ec9d6a26916a3bffd4d62094700a65c094a9e262a4238a973a3a68"
    }
  },
  {
    "ts": null,
    "headline": "Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?",
    "summary": "MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline milestones.",
    "url": "https://finnhub.io/api/news?id=b907ff4df86d247236f04e8fce52bfa216457f8eb54af620ba725c09494accbd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753791960,
      "headline": "Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock?",
      "id": 136119271,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline milestones.",
      "url": "https://finnhub.io/api/news?id=b907ff4df86d247236f04e8fce52bfa216457f8eb54af620ba725c09494accbd"
    }
  }
]